Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a - Ingrid Pabinger; Nisha Jain; Bent Winding; Elisa Tsao; Raina Liesner; K. John Pasi; Stefan Lethagen; Michael Wang; Hideji Hanabusa; Bryce A. Kerlin; Beatrice Nolan; Roshni Kulkarni; et al. (Blood, 2016)